COVID-19
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients and (or) their families who met any one or more of the diagnostic criteria for rheumatic diseases; (2)Patients with rheumatism who have taken immunosuppressive drugs, such as glucocorticoids, DMARDs, one or more of the biologics, for at least 1 month before infection with COVID-19; (3)Patients with rheumatism who met the diagnostic criteria for novel coronavirus infection and were infected for the first time; (4)Patients with clear consciousness who could complete the questionnaire independently; (5)Patients =18 years old; (6)Patients agreed to join the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Other respiratory diseases other than the COVID-19 affecting the observation of the disease; (2)Women who are pregnant, planning to become pregnant or breastfeeding; (3)Patients with mental disorders, severe cognitive dysfunction, language disorders, and difficulty in accurately obtaining disease data
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Full recovery time of COVID-19;Clinical typing of COVID-19; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cough recovery time;Fever duration;Other symptom recovery time; | — |
Countries
China
Contacts
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine